ViGenCell Inc.
Developing T-cell immune therapies to treat cancer and other incurable diseases.
308080 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 금천구 가산로9길 66 더리즌밸리 지식산업센터(가산동), 서울특별시
- Website:
- https://www.vigencell.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ViGenCell Inc. is a biotechnology company specializing in the research and development of immune cell therapies. The company develops novel treatments for cancers and other incurable diseases, aiming to prolong life expectancy and enhance patient quality of life. Its core technology includes ViTier, a proprietary T-cell therapy platform that employs antigen-specific killer T cells to target and eliminate pathogens or tumor cells. Founded in 2013 as the first subsidiary of the Catholic University Technology Holdings, ViGenCell leverages clinically validated research to advance its therapeutic pipeline.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-15 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등거래계획보고서
|
Korean | 40.7 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.1 MB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.2 MB | ||
| 2025-04-30 00:00 |
Regulatory News Service
기타경영사항(자율공시) (iPSC(유도만능줄기세포) 유래 NK세포치료제 공동개발계약 체결)
|
Korean | 6.8 KB | ||
| 2025-04-17 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-17 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 12.6 KB | ||
| 2025-03-27 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 33.6 KB | ||
| 2025-03-27 00:00 |
Board/Management Information
대표이사변경
|
Korean | 10.6 KB | ||
| 2025-03-19 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 25.3 KB | ||
| 2025-03-19 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 395.3 KB | ||
| 2025-03-13 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.3 KB | ||
| 2025-03-13 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 90.2 KB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 818.4 KB | ||
| 2025-03-11 00:00 |
Share Issue/Capital Change
주식매수선택권행사
|
Korean | 17.9 KB |
Automate Your Workflow. Get a real-time feed of all ViGenCell Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ViGenCell Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
